CellaVision AB
STO:CEVI

Watchlist Manager
CellaVision AB Logo
CellaVision AB
STO:CEVI
Watchlist
Price: 220 SEK 2.56%
Market Cap: 5.2B SEK
Have any thoughts about
CellaVision AB?
Write Note

CellaVision AB
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

CellaVision AB
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
CellaVision AB
STO:CEVI
Other Long-Term Assets
kr1k
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
-64%
Elekta AB (publ)
STO:EKTA B
Other Long-Term Assets
kr828m
CAGR 3-Years
24%
CAGR 5-Years
16%
CAGR 10-Years
N/A
S
Surgical Science Sweden AB
STO:SUS
Other Long-Term Assets
kr14.7m
CAGR 3-Years
-23%
CAGR 5-Years
12%
CAGR 10-Years
N/A
Getinge AB
STO:GETI B
Other Long-Term Assets
kr998m
CAGR 3-Years
-12%
CAGR 5-Years
-12%
CAGR 10-Years
N/A
Arjo AB (publ)
STO:ARJO B
Other Long-Term Assets
kr558m
CAGR 3-Years
24%
CAGR 5-Years
9%
CAGR 10-Years
N/A
S
Stille AB
STO:STIL
Other Long-Term Assets
kr33.3m
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
20%
No Stocks Found

CellaVision AB
Glance View

Market Cap
5.2B SEK
Industry
Health Care

CellaVision AB engages in the provision of automated microscopy systems in the field of hematology. The company is headquartered in Lund, Skane and currently employs 200 full-time employees. The company went IPO on 2007-05-28. The firm develops and sells digital solutions for medical microscopy, as well as products enabling blood cell analysis and morphology diagnosis. CellaVision AB’s product portfolio consists of analyzers for automated medical microscopy analysis and software applications designed for remote access, competency testing and education. The analyzers include such brands as CellaVision DM96 and CellaVision DM1200, whereas the software applications are divided into CellaVision Body Fluid Application, CellaVision Remote Review Software and CellaVision Competency Software, among others. The firm operates four subsidiaries, based in Sweden, Canada, the United States and Japan. In June 2014, CellaVision AB acquired technology platform from Clear Lake Medical Foundation.

CEVI Intrinsic Value
268.65 SEK
Undervaluation 18%
Intrinsic Value
Price

See Also

What is CellaVision AB's Other Long-Term Assets?
Other Long-Term Assets
1k SEK

Based on the financial report for Sep 30, 2024, CellaVision AB's Other Long-Term Assets amounts to 1k SEK.

What is CellaVision AB's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
-64%

Back to Top